Switzerland

The Rise of HPAPI Molecules

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

Innovative Chemistry Between Mountains and Lakes

Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan, as well as EU facilities in the United Kingdom and Germany. But do not underestimate the role of the domestic regional clusters and industrial sites.

Made in Switzerland – Exported Worldwide

Life Science Valley in the Heart of Europe

Syngenta Completes Plant Expansions

Kolb Takes on the KLK OLEO Identity

The New Globalism

Quality and Reliability

Dottikon, Büchi and Systag: Faster Scale-up to Production

Novartis' Vasella Exit Opens Door to Roche Stake Sale

Actelion Shareholders Reject Biotech Firm's Pay Plans

Innovation as a Recipe for Success

Swiss Health Insurer Makes Claim Against Bayer Over Yasmin Pill

Six Hurt in Novartis Plant Chemical Leak

Clariant Profit Weakens with World Economy

Switzerland's Lonza to Cut 500 Jobs

Roche Sees More Cancer Success as Sales Top Forecast

Abend New CEO at Kolb

Swiss Companies Still Hungry for Quality Buys